INDIRA BOLLAMPALLY, M.D.
Pulmonary Disease Physician in WALL, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: INDIRA BOLLAMPALLY, M.D. filed 86 Medicare Part D claims in 2023 across WALL, New Jersey. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
INDIRA BOLLAMPALLY, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
INDIRA BOLLAMPALLY, M.D. at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New Jersey
How Pulmonary Disease Physician compares to other specialties among New Jersey providers
Pulmonary Disease Physician share within New Jersey
Pulmonary Disease Physician is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Pulmonary Disease Physician ABMS/AOA estimate
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Pulmonary Disease Physician US NPIs
Specialty board-certified rate — Pulmonary Disease Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
INDIRA BOLLAMPALLY, M.D. is a Pulmonary Disease Physician provider practicing in WALL, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1609856913. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
INDIRA BOLLAMPALLY, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 1540 HWY 138, WALL, NJ, 07719, with a listed phone of (732) 681-9045. NPI 1609856913 was issued on 01/20/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOLLAMPALLY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 86 prescription claims written by this provider, covering 38 Medicare beneficiaries and totaling roughly $16K in drug spend, split 42% brand-name and 58% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1609856913 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 01/20/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm INDIRA BOLLAMPALLY, M.D.'s current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Brand vs generic prescribing mix · Above average
42% brand-name claims vs 58% generic, on 86 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 134
- Total Day Supply
- 3,849
- Brand vs Generic
- 42% brand / 58% generic
- Brand Drug Cost
- $12K
- Generic Drug Cost
- $5K
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.63
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How INDIRA BOLLAMPALLY, M.D. fits within the Pulmonary Disease Physician landscape nationally.
INDIRA BOLLAMPALLY, M.D.'s 86 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as BOLLAMPALLY.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is INDIRA BOLLAMPALLY, M.D.'s specialty? ▼
How much does INDIRA BOLLAMPALLY, M.D. prescribe under Medicare Part D? ▼
Where is INDIRA BOLLAMPALLY, M.D. located? ▼
What is INDIRA BOLLAMPALLY, M.D.'s NPI number? ▼
Does INDIRA BOLLAMPALLY, M.D. prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does INDIRA BOLLAMPALLY, M.D. prescribe most often? ▼
Does INDIRA BOLLAMPALLY, M.D. accept Medicare? ▼
How can I verify INDIRA BOLLAMPALLY, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology